Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 6, 2025, it ...
Craig-Hallum analyst William Bonello maintained a Buy rating on Guardant Health (GH – Research Report) today. The company’s shares closed ...
We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at ...
1d
Zacks.com on MSNAre Medical Stocks Lagging Guardant Health (GH) This Year?The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Guardant Health (GH) is a stock that can certainly grab the ...
We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results ...
Learn more about whether Guardant Health, Inc. or Premier, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
SG Americas Securities LLC decreased its position in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 43.1% during the 4th ...
Begin your TipRanks Premium journey today. Guardant Health (GH) Company Description: Guardant Health, Inc. is a precision oncology company, which engages in provision of precision oncology testing ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and ConcertAI, a leading oncology real-world evidence data and AI SaaS technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results